Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale
| Autor: | K. W Tupper, Ayden I. Scheim, Daniel Beriault, Nazlee Maghsoudi, P. Leece, Tara Marie Watson, Dan Werb, R. D MacDonald, L. Kufner, Kate Mason, K. McDonald, Cristiana Stefan, Lorraine Barnaby, J. Caldwell, R. Nisenbaum, Jason Altenberg |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Recreational Drug Service delivery framework Population Overdose 030508 substance abuse Medicine (miscellaneous) 03 medical and health sciences 0302 clinical medicine medicine Humans 030212 general & internal medicine education Ontario Harm reduction education.field_of_study Social work Public health Research lcsh:Public aspects of medicine Public Health Environmental and Occupational Health Opioid overdose lcsh:RA1-1270 medicine.disease 3. Good health Fentanyl Drug market monitoring Psychiatry and Mental health Health psychology Research Design Business Medical emergency Drug checking services Drug Overdose 0305 other medical science Drug Contamination Program Evaluation |
| Zdroj: | Harm Reduction Journal, Vol 17, Iss 1, Pp 1-10 (2020) Harm Reduction Journal |
| ISSN: | 1477-7517 |
| Popis: | Background The increasing incidence of fatal opioid overdose is a public health crisis in Canada. Given growing consensus that this crisis is related to the presence of highly potent opioid adulterants (e.g., fentanyl) in the unregulated drug supply, drug checking services (DCS) have emerged as part of a comprehensive approach to overdose prevention. In Canada’s largest city, Toronto, a network of DCS launched in 2019 to prevent overdose and overdose-related risk behaviors. This network employs mass spectrometry technologies, with intake sites co-located with supervised consumption services (SCS) at three frontline harm reduction agencies. The protocol and rationale for assessing the impact of this multi-site DCS network in Toronto is described herein. The aims of this study are to (1) evaluate the impact of DCS access on changes in and factors influencing overdose and related risk behaviors, (2) investigate the perceived capacity of DCS to prevent overdose, and (3) identify composition (qualitative and quantitative) trends in Toronto’s unregulated drug supply. Methods We will use a parallel-mixed-methods design with complementary data sources (including data from chemical analysis of drug samples, quantitative intake and post-test surveys, SCS, coroners, paramedic services, and qualitative interviews), followed by a meta-inference process wherein results from analyses are synthesized. Results Whereas most DCS globally target “recreational drug users,” in Toronto, this networked DCS will primarily target marginalized people who use drugs accessing frontline services, many of whom use drugs regularly and by injection. This evolution in the application of DCS poses important questions that have not yet been explored, including optimal service delivery models and technologies, as well as unique barriers for this population. Increasing information on the unregulated drug supply may modify the risk environment for this population of people who use drugs. Conclusions This study addresses evidence gaps on the emerging continuum of overdose prevention responses and will generate critical evidence on a novel approach to reducing the ongoing high incidence of drug-related morbidity and mortality in Canada and elsewhere. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |